Breaking News Instant updates and real-time market news.

RIGL

Rigel Pharmaceuticals

$3.35

0.01 (0.30%)

14:34
04/12/18
04/12
14:34
04/12/18
14:34

Rigel gives up gains after saying approval posted in error

Shares of Rigel Pharmaceuticals gave back a large part of today's gains after the company told Bloomberg that the approval posted on its Investors webpage was done in error. The company has not received notice from the FDA on the approval of Tavalisse, it said to the news agnecy. The FDA action date for the drug is April 17. Rigel shares, which jumped as high as 40% on the day, are now only up 10% to $3.71.

  • 17

    Apr

RIGL Rigel Pharmaceuticals
$3.35

0.01 (0.30%)

04/03/18
JEFF
04/03/18
NO CHANGE
Target $5
JEFF
Buy
Rigel selloff on IgAN trial miss overdone, says Jefferies
Jefferies analyst Eun Yang called the fact that Rigel Pharmaceuticals' Phase 2 trial evaluating fostamatinib in IgAN failed to meet its primary endpoint "somewhat disappointing," but also said the news does not change his valuation or view on the approvability in patients with chronic or persistent immune thrombocytopenia. The analyst, who said the company is "completely optimistic" for timely approval of fostamatinib in the ITP indication by the PDUFA date of April 17, keeps a Buy rating and $5 price target on Rigel shares, calling today's selloff "overdone."
04/03/18
HCWC
04/03/18
NO CHANGE
Target $6.7
HCWC
Buy
H.C. Wainwright says Rigel's 'small setback' a buying opportunity ahead of PDUFA
H.C. Wainwright analyst Joseph Pantginis called news that Rigel Pharmaceuticals' Phase 2 study of fostamatinib in patients with IgA nephropathy did not meet its primary endpoint a "small setback" for the company and an opportunity for investors. He believes today's selling pressure is an overreaction, adding that "brighter skies may be tomorrow, almost literally," with the company's PDUFA date for fostamatinib in ITP coming on April 17. Pantginis reiterates a Buy rating on Rigel and trimmed his price target on the stock to $6.70 from $7.
04/04/18
JEFF
04/04/18
NO CHANGE
Target $5
JEFF
Buy
Rigel selloff yesterday on failed study overdone, says Jefferies
Jefferies analyst Eun Yang says that while yesterday's Phase 2 trial results in IgA nephropathy, fostamatinib's third indication, is "somewhat disappointing," it does not change her valuation or upcoming approvability in first indication immune thrombocytopenic purpura. The analyst views the selloff yesterday in shares of Rigel Pharmaceuticals as overdone. She believes the failed study has no bearing on the approval in ITP, which has an FDA action date of April 17. Yang reiterates a Buy rating on Rigel with a $5 price target.
04/09/18
JPMS
04/09/18
NO CHANGE
JPMS
Overweight
Rigel Pharmaceuticals shares can rally 80% on FDA approval, says JPMorgan
JPMorgan analyst Anupam Rama continues to see a favorable risk/reward profile on Rigel Pharmaceuticals heading into the April 17 FDA action date for Tavalisse in immune thrombocytopenia. The analyst sees a "high probability" of approval for Tavalisse and 50%-80% share upside on the news, "assuming no major surprises in the label." The approval is setting up to be a "true binary event," with potential share downside in the 65%-80% range, Rama tells investors in a research note. He keeps an Overweight rating on Rigel shares.

TODAY'S FREE FLY STORIES

EWW

iShares MSCI Mexico

$49.18

-0.055 (-0.11%)

06:45
08/17/18
08/17
06:45
08/17/18
06:45
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$25.59

-0.01 (-0.04%)

06:44
08/17/18
08/17
06:44
08/17/18
06:44
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$21.16

(0.00%)

06:44
08/17/18
08/17
06:44
08/17/18
06:44
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$54.27

-0.07 (-0.13%)

, EQGP

EQT GP

$22.25

0.2 (0.91%)

06:43
08/17/18
08/17
06:43
08/17/18
06:43
Recommendations
EQT Midstream Partners, EQT GP analyst commentary  »

EQT Midstream price…

EQM

EQT Midstream Partners

$54.27

-0.07 (-0.13%)

EQGP

EQT GP

$22.25

0.2 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$49.85

0.61 (1.24%)

06:41
08/17/18
08/17
06:41
08/17/18
06:41
Recommendations
EQT Corporation analyst commentary  »

EQT Corporation price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COT

Cott Corp.

$15.64

0.13 (0.84%)

06:37
08/17/18
08/17
06:37
08/17/18
06:37
Initiation
Cott Corp. initiated  »

Cott Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$0.03

-0.0172 (-36.44%)

06:36
08/17/18
08/17
06:36
08/17/18
06:36
Periodicals
MoviePass puts additional restrictions on subscribers, NY Post says »

MoviePass chief Mitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFET

Safe-T

$0.00

(0.00%)

06:36
08/17/18
08/17
06:36
08/17/18
06:36
Syndicate
Safe-T raises $7.335M in a registered direct offering »

Safe-T announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$32.83

0.44 (1.36%)

, FB

Facebook

$174.76

-4.78 (-2.66%)

06:33
08/17/18
08/17
06:33
08/17/18
06:33
Periodicals
Twitter CEO criticizes Facebook, YouTube for Alex Jones' removal, BI reports »

Twitter (TWTR) CEO Jack…

TWTR

Twitter

$32.83

0.44 (1.36%)

FB

Facebook

$174.76

-4.78 (-2.66%)

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 06

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

AZRE

Azure Power

$15.95

-0.405 (-2.48%)

06:30
08/17/18
08/17
06:30
08/17/18
06:30
Initiation
Azure Power initiated  »

Azure Power initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

$0.00

(0.00%)

, AAPL

Apple

$213.49

3.21 (1.53%)

06:26
08/17/18
08/17
06:26
08/17/18
06:26
Periodicals
Foxconn to launch semiconductor plant in China's Pearl River Delta, WSJ says »

Foxconn Technology, …

HNHPF

Hon Hai Precision

$0.00

(0.00%)

AAPL

Apple

$213.49

3.21 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUMC

Yum China

$35.33

0.29 (0.83%)

06:26
08/17/18
08/17
06:26
08/17/18
06:26
Downgrade
Yum China rating change  »

Yum China downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

LGND

Ligand

$239.84

-7.88 (-3.18%)

06:25
08/17/18
08/17
06:25
08/17/18
06:25
Initiation
Ligand initiated  »

Ligand initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

, GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

06:24
08/17/18
08/17
06:24
08/17/18
06:24
Periodicals
Google CEO responds to criticism over plan for search engine in China, WSJ says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

BXG

Bluegreen Vacations

$20.39

-0.65 (-3.09%)

06:22
08/17/18
08/17
06:22
08/17/18
06:22
Downgrade
Bluegreen Vacations rating change  »

Bluegreen Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$137.38

1.68 (1.24%)

06:21
08/17/18
08/17
06:21
08/17/18
06:21
Earnings
Deere reports Q3 EPS 2.78, consensus $2.75 »

Reports Q3 worldwide net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

WMT

Walmart

$98.63

8.39 (9.30%)

, COST

Costco

$223.20

1.55 (0.70%)

06:20
08/17/18
08/17
06:20
08/17/18
06:20
Recommendations
Walmart, Costco, Target analyst commentary  »

Walmart price target…

WMT

Walmart

$98.63

8.39 (9.30%)

COST

Costco

$223.20

1.55 (0.70%)

TGT

Target

$82.07

1.38 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 04

    Oct

KORS

Michael Kors

$71.94

0.63 (0.88%)

06:20
08/17/18
08/17
06:20
08/17/18
06:20
Recommendations
Michael Kors analyst commentary  »

Michael Kors price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

ENB

Enbridge

$34.89

-0.19 (-0.54%)

06:18
08/17/18
08/17
06:18
08/17/18
06:18
Upgrade
Enbridge rating change  »

Enbridge upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAY

Dave & Buster's

$53.58

1.24 (2.37%)

06:17
08/17/18
08/17
06:17
08/17/18
06:17
Recommendations
Dave & Buster's analyst commentary  »

Dave & Buster's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$137.38

1.68 (1.24%)

06:16
08/17/18
08/17
06:16
08/17/18
06:16
Hot Stocks
Deere CEO says 'continue face cost pressures for raw materials and freight' »

"Deere's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

FB

Facebook

$174.76

-4.78 (-2.66%)

06:15
08/17/18
08/17
06:15
08/17/18
06:15
Periodicals
Facebook begins to crack down on opioid dealers, TechCrunch reports »

Facebook's internal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 06

    Sep

  • 18

    Sep

TM

Toyota

$122.76

0.9 (0.74%)

06:14
08/17/18
08/17
06:14
08/17/18
06:14
Periodicals
Toyota to boost production capacity in China by 20%, Reuters says »

Toyota will add more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$137.38

1.68 (1.24%)

06:13
08/17/18
08/17
06:13
08/17/18
06:13
Earnings
Deere sees FY18 equipment revenue up about 30%, consensus $33.78B »

Company equipment sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

SUI

Sun Communities

06:12
08/17/18
08/17
06:12
08/17/18
06:12
Downgrade
Sun Communities rating change  »

Sun Communities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.